{
    "SPADE_UN_25094": {
        "Sequence Information": {
            "Peptide Name": "NK-2, NK-lysin (39-65)",
            "Sequence": "KILRGVCKKIMRTFLRRISKDILTGKK",
            "Sequence Length": 27,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiparasitic",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "Q29075",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/Q29075",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.",
                    "Pubmed ID": "21474443",
                    "Reference": "J Biol Chem. 2011;286:18692-18700",
                    "Author": "Andrä J, Goldmann T, Ernst CM, Peschel A, Gutsmann T",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21474443"
                },
                {
                    "Title": "Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.",
                    "Pubmed ID": "17389605",
                    "Reference": "J Biol Chem. 2007;282:14719-14728",
                    "Author": "Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17389605"
                },
                {
                    "Title": "The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.",
                    "Pubmed ID": "18332165",
                    "Reference": "Antimicrob Agents Chemother. 2008;52:1713-1720",
                    "Author": "Gelhaus C, Jacobs T, Andrä J, Leippe M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18332165"
                },
                {
                    "Title": "Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria.",
                    "Pubmed ID": "21396418",
                    "Reference": "Peptides. 2011;32:881-887",
                    "Author": "Jena P, Mishra B, Leippe M, Hasilik A, Griffiths G, Sonawane A",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21396418"
                },
                {
                    "Title": "The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine.",
                    "Pubmed ID": "16269280",
                    "Reference": "FEBS Lett. 2005;579:6128-6134",
                    "Author": "Schröder-Borm H, Bakalova R, Andrä J",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16269280"
                },
                {
                    "Title": "Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages.",
                    "Pubmed ID": "23689720",
                    "Reference": "Antimicrob Agents Chemother. 2013;57:3688-3698",
                    "Author": "Mohanty S, Jena P, Mehta R, Pati R, Banerjee B, Patil S, Sonawane A",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23689720"
                },
                {
                    "Title": "Designing Anticancer Peptides by Constructive Machine Learning.",
                    "Pubmed ID": "29679519",
                    "Reference": "ChemMedChem. 2018;13:1300-1302",
                    "Author": "Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29679519"
                },
                {
                    "Title": "Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2.",
                    "Pubmed ID": "29043494",
                    "Reference": "Probiotics Antimicrob Proteins. 2018;10:118-127",
                    "Author": "Yan J, Liang X, Liu C, Cheng Y, Zhou L, Wang K , Zhao L",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29043494"
                }
            ],
            "Mass": 3203.01,
            "PI": 11.6,
            "Net Charge": 9,
            "Hydrophobicity": -0.26,
            "Frequent Amino Acids": "KIR",
            "Absent Amino Acids": "AEHNOPQUWY",
            "Basic Residues": 10,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 11,
            "Polar Residues": 16,
            "Positive Residues": 10,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_UN_25094",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02580",
                    "Similarity": 1.0,
                    "Sequence": "GLICESCRKIIQKLEDMVGPQPNEDTVTQAASRVCDKMKILRGVCKKIMRTFLRRISKDILTGKKPQAICVDIKICKE"
                },
                {
                    "SPADE_ID": "SPADE_N_03948",
                    "Similarity": 1.0,
                    "Sequence": "GLICESCRKIIQKLEDMVGPQPNEDTVTQAASRVCDKMKILRGVCKKIMRTFLRRISKDILTGKKPQAICVDIKICKEKTGLI"
                },
                {
                    "SPADE_ID": "SPADE_N_07586",
                    "Similarity": 1.0,
                    "Sequence": "LICESCRKIIQKLEDMVGPQPNEDTVTQAASRVCDKMKILRGVCKKIMRTFLRRISKDILTGKKPQAICVDIKICKE"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=100 µg/ml,Human erythrocytes:50% Hemolysis=281±48 µM,Mouse erythrocytes:33% Hemolysis=75 µM",
            "Target Organism": "Staphylococcus aureus SA113(MIC=32µg/ml),Staphylococcus aureus SA113(MIC=>256µg/ml),Staphylococcus aureus SA113(MBC=256µg/ml),Staphylococcus aureus SA113(MBC=>256µg/ml),Staphylococcus aureus Del-mprF(MIC=8µg/ml),Staphylococcus aureus Del-mprF(MIC=8µg/ml),Staphylococcus aureus Del-mprF(MBC=16µg/ml),Staphylococcus aureus Del-mprF(MBC=16µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MIC=8µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MIC=8µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MBC=16µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MBC=16µg/ml),Staphylococcus aureus(MIC=64µg/ml),Staphylococcus aureus(MIC=64µg/ml),Staphylococcus aureus(MBC=128µg/ml),Staphylococcus aureus(MBC=128µg/ml),Escherichia coli ATCC 25922(MIC=16µg/ml),Acinetobacter baumannii ATCC 19606(MIC=2µg/ml),Bordetella bronchiseptica CUN 11844-99(MIC=4µg/ml),Brucella abortus 9.49 (per-)(MIC=32µg/ml),Pseudomonas aeruginosa CUN 4158-02(MIC=32µg/ml),Yersinia pestis KIM pYV(MIC=>256µg/ml),Staphylococcus aureus ATCC 43300(MIC=256µg/ml),Escherichia coli ATCC 23716(MIC=0.25µg/ml),Escherichia coli ATCC 23716(MIC=16µg/ml),Human cervical carcinoma HeLa(30-40% Cytotoxicity=100µg/ml),Plasmodium falciparum(LC50=6.2µM),Mycobacterium smegmatis(70-80% Killing=30µM),Mycobacterium bovis BCG(80-90% Killing=30µM),Human histiocytic lymphoma U-937(LD50=30µM),Human colon adenocarcinoma SW480(LD50=1-4µM),Human myelogenous leukemia K562(LD50=1-4µM),Human neuroblastoma LA-N-1(LD50=1-4µM),Human neuroblastoma SH-SY5Y(LD50=1-4µM),Escherichia coli ATCC 25922(MBC=16µg/ml),Acinetobacter baumannii ATCC 19606(MBC=2µg/ml),Bordetella bronchiseptica CUN 11844-99(MBC=4µg/ml),Brucella abortus 9.49 (per-)(MBC=32µg/ml),Pseudomonas aeruginosa CUN 4158-02(MBC=32µg/ml),Yersinia pestis KIM pYV(MBC=>256µg/ml),Staphylococcus aureus ATCC 43300(MBC=256µg/ml),Escherichia coli ATCC 23716(MBC=0.25µg/ml),Escherichia coli ATCC 23716(MBC=32µg/ml),Mycobacterium smegmatis mc2-155(no activity data),Mycobacterium smegmatis mc2-155(MBC90=17.5µg/ml),Mycobacterium marinum ATCC 927(MBC90=3.5µg/ml),Murine macrophage cells RAW 264.7(no activity data),Human breast adenocarcinoma MCF-7(EC50=30±3µM),Escherichia coli CMCC 44102(MIC=4µM),Pseudomonas aeruginosa ATCC 27853(MIC=8µM),Staphylococcus aureus CMCC 26003(MIC=2µM),Staphylococcus epidermidis ATCC 12228(MIC=2µM),Human bladder cancer BIU-87(IC50=25µM),Human bladder cancer EJ(IC50=10µM),Human prostate adenocarcinoma PC-3(IC50=5µM),Human bladder carcinoma T24(IC50=12µM),Human promyelocytic leukemia HL-60(IC50=15µM),Human myelogenous leukemia K562(IC50=>50µM)"
        }
    }
}